Study Of Telemedicine Consultation at Home For Older Adults
The system of medical care for older adults with acute illnesses often serves them poorly. Many factors limit these patients' access to safe, patient-centered, efficient, high-quality, acute care. These factors include a shortage of geriatricians and primary care physicians; limited availability of timely, acute-illness, patient appointments; emergency department (ED) crowding; interruptions to the continuity of care when patients use the ED; and poor transitions of care from the ambulatory setting to the ED. These conditions foster unnecessary ED use, adverse events in the ED for which older adults are particularly at-risk, and unnecessary medical costs. As the population ages, the magnitude of these problems will only increase.
The overarching study goals are to develop and evaluate a telemedicine-enhanced care model that improves access to safe, high-quality, acute illness care for older adults; fosters appropriate use of health services; and reduces unnecessary expenditures. Specifically, this study aims to:
Expand the existing pediatric HeA telemedicine network to older adults by providing senior living communities (SLC) with an alternative on-site care option for individuals with an acute illness episode.
Hypothesis 1: 90% of requested telemedicine visits will be successfully completed.
Evaluate the impact of the HeA telemedicine model on utilization, quality of care, and patient safety.
Hypothesis 2: The rate of ED use will be lower at SLCs with access to care via telemedicine, as compared to SLCs without such access to care.
Hypothesis 3: Quality of care and patient safety measures will be better for SLC residents with access to telemedicine-enhanced care than for residents without this form of access.
Evaluate the economic benefit of the care delivered through the telemedicine network.
Hypothesis 4: The net cost of healthcare per patient-month will be less for SLC residents with access to telemedicine-enhanced care than for those without this form of access.
- Use qualitative methods to identify strategies and assets that promote and conditions that impede the implementation, acceptance, and success of the HeA telemedicine network in SLCs. This knowledge will inform efforts to develop a toolkit to be used to disseminate this technology broadly.
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||Study Of Telemedicine Consultation at Home For Older Adults|
- Emergency department use [ Time Frame: Up to 33 months ] [ Designated as safety issue: No ]Use of emergency department by individuals with access to care via telemedicine as compared to those without such access to care.
- Quality of acute illness communication to emergency departments [ Time Frame: Upon ED visit during 33 months of follow up ] [ Designated as safety issue: Yes ]Chart review of communication from primary care to ED based on a developed data sheet examining a number of metrics
- Adherence to advanced directives [ Time Frame: Up to 33 months ] [ Designated as safety issue: No ]Adherence to advanced directives.
- Satisfaction of patients, providers, and family experiencing telemedicine [ Time Frame: Up to 33 months ] [ Designated as safety issue: No ]Response to satisfaction survey regarding experience with telemedicine
- Cost of care [ Time Frame: Up to 33 months ] [ Designated as safety issue: No ]Comparison of cost of care between intervention and control groups.
|Study Start Date:||October 2010|
|Estimated Study Completion Date:||December 2015|
|Primary Completion Date:||June 2014 (Final data collection date for primary outcome measure)|
Group without access to telemedicine in the home for acute care issues.
Cohort with access to telemedicine in the home for acute care issues.
Other: Telemedicine care
Availability of telemedicine
Other Name: Telemedicine
Please refer to this study by its ClinicalTrials.gov identifier: NCT01324687
|United States, New York|
|University of Rochester|
|Rochester, New York, United States, 14642|
|Principal Investigator:||Manish N. Shah, MD||University of Rochester|
|Principal Investigator:||Kenneth McConnochie, MD||University of Rochester|